Back
HFA Premium Access

Development of significant atrial fibrillation over 18 months in the RESPIRE study in unselected pacemaker patients with or without severe sleep apnoea

Session: Poster Session 3 - Atrial Fibrillation - Epidemiology, Prognosis, Outcome
Topic: Epidemiology, Prognosis, Outcome
Speaker: Doctor P. Marques (Lisbon, PT)
Event: Heart Failure 2018

Congress Presentation

Add to my library

Like

About the speaker

Doctor Pedro Marques

CHULN and Faculty of medicine of the University of Lisbon, Lisbon (Portugal)
0 follower

4 more presentations in this session

Clinical characteristics of patients with heart failure with mid-range ejection fraction and atrial fibrillation

Speaker: Professor G. Giannakoulas (Thessaloniki, GR)

Access
Abstract
Slides
Like
Thumbnail

Mid-term outcomes in heart failure patients treated with non-vitamin K antagonist oral anticoagulants. A real world study.

Speaker: Doctor C. Goena Vives (Donostia, ES)

Access
Abstract
Slides
Like
Thumbnail

Development of persistent atrial fibrillation over 18 months in the RESPIRE study in unselected pacemaker patients with or without severe sleep apnoea

Speaker: Doctor L. Jesel (Strasbourg, FR)

Access
Abstract
Slides
Like
Thumbnail

Holter monitoring value in cardioembolic stroke: a follow up study

Speaker: Doctor H. Nascimento (Santa Maria da Feira, PT)

Access
Abstract
Like
Thumbnail

Access the full session

Poster Session 3 - Atrial Fibrillation - Epidemiology, Prognosis, Outcome

Speakers: Doctor P. Marques, Professor G. Giannakoulas, Doctor C. Goena Vives, Doctor L. Jesel, Doctor H. Nascimento
Access
Like
Thumbnail

About the event

Image

Heart Failure 2018

26 May - 29 May 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources